BeOne Medicines
ONC
#650
Rank
A$53.77 B
Marketcap
A$485.93
Share price
-2.56%
Change (1 day)
49.79%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total debt

Total debt on the balance sheet as of September 2025 : A$1.53 Billion

According to BeOne Medicines's latest financial reports the company's total debt is A$1.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BeOne Medicines - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$1.73 B27.16%
2023-12-31A$1.36 B55.71%
2022-12-31A$0.87 B-8.49%
2021-12-31A$0.95 B31.1%
2020-12-31A$0.73 B84.5%
2019-12-31A$0.39 B40.65%
2018-12-31A$0.28 B33.48%
2017-12-31A$0.21 B779.9%
2016-12-31A$23.97 M-15.96%
2015-12-31A$28.53 M68.75%
2014-12-31A$16.9 M-44.88%
2013-12-31A$30.67 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$0.59 B-61.23%๐Ÿ‡บ๐Ÿ‡ธ USA